Anti-MBD2 + MBD3 antibody [106B691]
5
(1 Review)
|
(11 Publications)
Mouse Monoclonal MBD2 antibody. Suitable for WB, IHC-P, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 11 publications. Immunogen corresponding to Synthetic Peptide within Human MBD2 aa 200-250.
View Alternative Names
Methyl-CpG-binding domain protein 2, Demethylase, Methyl-CpG-binding protein MBD2, DMTase, MBD2
- IHC-P
AbReview22085****
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MBD2 + MBD3 antibody [106B691] (AB45027)
ab45027 at 2μg/ml staining MBD2 + MBD3 in human glioma tissue by Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections).
Tissue was fixed in paraformaldehyde and a heat mediated antigen retrieval step was performed and samples were blocked using 10% BSA. The secondary used was an HRP conjugated anti rabbit/mouse mix.
Image courtesy of an anonymous Abreview.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-MBD2 + MBD3 antibody [106B691] (AB45027)
Overlay histogram showing HeLa cells stained with ab45027 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab45027, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells ) used under the same conditions. Acquisition of >5,000 events was performed.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MBD2 + MBD3 antibody [106B691] (AB45027)
Immunohistochemistry analysis of immersion fixed paraffin-embedded sections of human placenta labeling MBD2 + MBD3 with ab45027 at 1/300 for 1 hour at room temperature followed by incubation with the Anti-Mouse IgG VisUCyte™ HRP Polymer Antibody. Tissue was stained using DAB (brown) and counterstained with hematoxylin (blue).
- WB
Supplier Data
Western blot - Anti-MBD2 + MBD3 antibody [106B691] (AB45027)
All lanes:
Western blot - Anti-MBD2 + MBD3 antibody [106B691] (ab45027) at 2 µg/mL
Lane 1:
HeLa cell lysate (nuclear fraction) without immunising peptide
Lane 2:
HeLa cell lysate (nuclear fraction) with immunising peptide
Predicted band size: 45 kDa
Observed band size: 160 kDa,33 kDa,40 kDa,45 kDa
false
Reactivity data
Product details
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MBD2 and MBD3 participate in gene silencing and chromatin remodeling. They act as part of the NuRD (nucleosome remodeling and deacetylase) complex which integrates both chromatin remodeling and histone deacetylase activities to regulate transcription. Within this complex MBD2 associates with co-repressor proteins and may directly influence transcriptional repression activities. MBD3 although structurally similar lacks strong methyl-CpG binding and may have a more regulatory role in the NuRD complex.
Pathways
MBD2 and MBD3 influence epigenetic regulatory pathways including those involved in gene expression and genomic imprinting. They interact with pathways that involve DNA methylation and histone modification. Within these pathways MBD2 and MBD3 closely work with proteins such as HDAC1 and HDAC2 which are integral to the deacetylation processes in chromatin remodeling. Their roles in these pathways are important for maintaining cellular identity and regulating developmental processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
The EMBO journal 42:e113448 PubMed37737560
2023
Applications
Unspecified application
Species
Unspecified reactive species
Genome research 28:1646-1655 PubMed30254051
2018
Applications
Unspecified application
Species
Unspecified reactive species
Cell metabolism 23:881-92 PubMed27166947
2016
Applications
Unspecified application
Species
Unspecified reactive species
Oncotarget 7:14476-85 PubMed26910839
2016
Applications
WB
Species
Unspecified reactive species
Molecular cell 56:738-48 PubMed25453762
2014
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 15:16719-40 PubMed25244019
2014
Applications
WB
Species
Frog
Cancer research 71:5859-70 PubMed21724586
2011
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 4:e6617 PubMed19672297
2009
Applications
IHC-FoFr
Species
Human
Neurobiology of aging 31:2025-37 PubMed19117641
2009
Applications
IHC-Fr
Species
Human
Human molecular genetics 14:785-97 PubMed15689352
2005
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com